SCHEMBL515589

SCHEMBL515589

CC(N)C(ON1CCCC1)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 6/20 0.40
CYP1A2 P05177 4/20 0.40
CYP3A4 P08684 4/20 0.40
CYP2C9 P11712 4/20 0.40
KCNA5 P22460 4/20 0.40
CYP2C19 P33261 4/20 0.40
KCNH2 Q12809 4/20 0.40
LMNA P02545 2/20 0.40
ADRA2A P08913 1/20 0.40
ADRA2C P18825 1/20 0.40
HIF1A Q16665 1/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 2/20 0.39
KCNE1 P15382 1/20 0.39
DPP4 P27487 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
MC4R P32245 1/20 0.36
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cadaverine Tartrate SCHEMBL16685626 0.89 LMNA (0.44) CYP2D6CYP1A2CYP3A4LMNAADRA2A
SCHEMBL515536 0.85 CYP3A4 (0.40) CYP2D6CYP3A4KCNA5CYP2C19LMNA
SCHEMBL16685702 0.82 TP53 (0.51) CYP2D6CYP1A2CYP2C19LMNAALDH1A1
SCHEMBL16685629 0.80 LMNA (0.39) CYP2D6CYP1A2CYP3A4LMNAADRA2A
SCHEMBL8082292 0.80 CYP2D6 (0.43) CYP2D6CYP1A2CYP3A4CYP2C9KCNA5
SCHEMBL7480934 0.77 CYP2D6 (0.47) CYP2D6CYP1A2CYP3A4CYP2C9KCNA5
SCHEMBL28042294 0.75 CYP2D6 (0.50) CYP2D6CYP1A2CYP3A4CYP2C9KCNA5
Hydrochloric Acid SCHEMBL29424742 0.75 CYP2D6 (0.46) CYP2D6CYP1A2CYP3A4CYP2C9KCNA5
SCHEMBL1802065 0.74 CYP3A4 (0.52) CYP2D6CYP1A2CYP3A4CYP2C9KCNA5
Hydrochloric Acid SCHEMBL7654483 0.72 CYP3A4 (0.50) CYP2D6CYP1A2CYP3A4CYP2C9KCNA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110382470-B Preparation method of efavirenz 纳尔逊·曼德拉都市大学 2023-06-06 CN claimed
CN-110382470-A The preparation method of efavirenz 纳尔逊·曼德拉都市大学 2019-10-25 CN claimed
EP-3548469-A1 METHOD FOR THE MANUFACTURE OF EFAVIRENZ Nelson Mandela Metropolitan University (ZA) 2019-10-09 EP claimed
CN-104805148-B The biological preparation method of one kind (1R, 2S)-N- pyrrolidinyl norephedrine 苏州汉酶生物技术有限公司 2019-02-01 CN claimed
WO-2018154414-A1 METHOD FOR THE MANUFACTURE OF EFAVIRENZ NELSON MANDELA METROPOLITAN UNIVERSITY (ZA) 2018-08-30 WO claimed
WO-2015063795-A2 NOVEL PROCESS FOR PREPARATION OF OPTICALLY PURE NOREPHEDRINE AND ITS DERIVATIVES LAURUS LABS PRIVATE LIMITED (IN) 2015-05-07 WO claimed
WO-2011141934-A1 AN IMPROVED PROCESS FOR THE PREPARATION OF AN INTERMEDIATE OF HMG-COA REDUCTASE INHIBITORS MATRIX LABORATORIES LTD. (IN) 2011-11-17 WO claimed
EP-0981520-A1 EFFICIENT ENANTIOSELECTIVE ADDITION REACTION USING AN ORGANOZINC REAGENT Merck & Co., Inc. (US) 2000-03-01 EP claimed
WO-1998051676-A1 EFFICIENT ENANTIOSELECTIVE ADDITION REACTION USING AN ORGANOZINC REAGENT MERCK & CO., INC. (US) 1998-11-19 WO claimed
CN-110382470-B Preparation method of efavirenz 纳尔逊·曼德拉都市大学 2023-06-06 CN disclosed
CN-110382470-A The preparation method of efavirenz 纳尔逊·曼德拉都市大学 2019-10-25 CN disclosed
EP-3548469-A1 METHOD FOR THE MANUFACTURE OF EFAVIRENZ Nelson Mandela Metropolitan University (ZA) 2019-10-09 EP disclosed
CN-104805148-B The biological preparation method of one kind (1R, 2S)-N- pyrrolidinyl norephedrine 苏州汉酶生物技术有限公司 2019-02-01 CN disclosed
CN-104805148-B The biological preparation method of one kind (1R, 2S)-N- pyrrolidinyl norephedrine 苏州汉酶生物技术有限公司 2019-02-01 CN disclosed
US-5698741-A HIV REVERSE TRANSCRIPTASE INHIBITOR MERCK & CO. INC. (US) 1997-12-16 US disclosed
EP-0805790-A1 IMPROVED SYNTHESIS OF CYCLOPROPYLACETYLENE Merck & Co., Inc. (US) 1997-11-12 EP disclosed
US-5663467-A BASIC REACTION OF 5-HALO-1-PENTYNE IN APROTIC SOLVENT, HEATING AND CYCLIZATION THEN QUENCHING MERCK & CO., INC. (US) 1997-09-02 US disclosed
US-5633405-A REACTING SUBSTITUTED NOREPHEDRINE WITH CYCLOPROPYLACETYLENE AND LITHIATING AGENT IN APROTIC SOLVENT, MIXING WITH ANILINE TRIFLUOROMETHYL KETONE, QUENCHING WITH PROTON SOURCE MERCK & CO., INC. (US) 1997-05-27 US disclosed
WO-1996037457-A1 ASYMMETRIC SYNTHESIS OF (-) 6-CHLORO-4-CYCLOPROPYL-ETHYNYL-4-TRIFLUOROMETHYL-1,4-DIHYDRO-2H-3,1-BENZOXAZIN-2-ONE MERCK & CO., INC. (US) 1996-11-28 WO disclosed
WO-1996022955-A1 IMPROVED SYNTHESIS OF CYCLOPROPYLACETYLENE MERCK & CO., INC. (US) 1996-08-01 WO disclosed